RVT-3101 for the Treatment of Moderate to Severe Active Crohn's Disease

Condition:   Crohn Disease Intervention:   Drug: RVT-3101 Sponsor:   Telavant, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials